Renaissance Technologies’s Alamar Biosciences ALMR Stock Holding History

Renaissance Technologies’s Portfolio ALMR Stock Details ALMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.18M	Buy	+122,690	New	+$3.61M	0.01%	1559

Other funds holding ALMR

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.45B AUM 70.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $33.4B AUM 56.97% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Nikko Asset Management Americas New York $8.04B AUM 33.34% 1-Year Est. Return

Renaissance Technologies's ALMR Position: Q3 2026 in Review

Renaissance Technologies opened a new position in Alamar Biosciences (ALMR) in Q3 2026: 122,690 shares worth $4.18M. The stake represents 0.01% of the portfolio and ranks #1559 among its holdings.

47 funds tracked by Wall St. Rank hold ALMR as of Q3 2026.

Renaissance Technologies held 122,690 shares of Alamar Biosciences worth $4.18M as of Q3 2026.
Alamar Biosciences was a new Renaissance Technologies position in Q3 2026.
Alamar Biosciences made up 0.01% of Renaissance Technologies's portfolio in Q3 2026, its #1559 holding.
47 funds tracked by Wall St. Rank held Alamar Biosciences as of Q3 2026.

Based on Renaissance Technologies's 13F filing for Q3 2026, filed 12 Nov 2026.